Logo Amazing ErasmusMC
NL
  • Homepage
  • Erasmus MC
  • Cookies
  • Disclaimer
  • Privacy

Posts per subject

IV

Pembrolizumab

Immune therapy prevents bladder removal for some bladder cancer patients

A proportion of patients with difficult-to-treat non-metastatic bladder cancer benefit from immunotherapy with the drug pembrolizumab. This has been shown by international research, which Erasmus MC Cancer Institute co-led. Annually, researchers estimate this new therapy could save about 50 patients in the Netherlands from having their bladder removed.

organoid bladder cancer

Urology

$3 million for research on bladder cancer and chemotherapy

American bladder cancer scientists have been awarded the prestigious R01 grant, together with urologist Dr. Tahlita Zuiverloon of the Erasmus MC Cancer Institute. The team will receive $3 million for research into the biology of chemotherapy resistance in bladder cancer.

Erasmus MC
  • Amazing Erasmus MC
  • Erasmus MC
  • Follow us
  • Facebook
  • Instagram
  • Twitter
  • LinkedIn
  • © 2022 Erasmus MC
  • Cookies
  • Disclaimer
  • Privacy